Patterns of Emphysema Heterogeneity

Background: Although lobar patterns of emphysema heterogeneity are indicative of optimal target sites for lung volume reduction (LVR) strategies, the presence of segmental, or sublobar, heterogeneity is often underappreciated. Objective: The aim of this study was to understand lobar and segmental patterns of emphysema heterogeneity, which may more precisely indicate optimal target sites for LVR procedures. Methods: Patterns of emphysema heterogeneity were evaluated in a representative cohort of 150 severe (GOLD stage III/IV) chronic obstructive pulmonary disease (COPD) patients from the COPDGene study. High-resolution computerized tomography analysis software was used to measure tissue destruction throughout the lungs to compute heterogeneity (≥15% difference in tissue destruction) between (inter-) and within (intra-) lobes for each patient. Emphysema tissue destruction was characterized segmentally to define patterns of heterogeneity. Results: Segmental tissue destruction revealed interlobar heterogeneity in the left lung (57%) and right lung (52%). Intralobar heterogeneity was observed in at least one lobe of all patients. No patient presented true homogeneity at a segmental level. There was true homogeneity across both lungs in 3% of the cohort when defining heterogeneity as ≥30% difference in tissue destruction. Conclusion: Many LVR technologies for treatment of emphysema have focused on interlobar heterogeneity and target an entire lobe per procedure. Our observations suggest that a high proportion of patients with emphysema are affected by interlobar as well as intralobar heterogeneity. These findings prompt the need for a segmental approach to LVR in the majority of patients to treat only the most diseased segments and preserve healthier ones.

[1]  A. Gulsvik,et al.  Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. , 1991, Thorax.

[2]  J. Verschakelen,et al.  Measurement of lung density by means of quantitative CT scanning. A study of correlations with pulmonary function tests. , 1992 .

[3]  U Stammberger,et al.  Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. , 1997, The Annals of thoracic surgery.

[4]  H A Vrooman,et al.  A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.

[5]  P. Gevenois,et al.  Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema. , 2001, The European respiratory journal.

[6]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[7]  G. Snell,et al.  Relation of interlobar collaterals to radiological heterogeneity in severe emphysema , 2006, Thorax.

[8]  P. Laveneziana,et al.  Physiology and consequences of lung hyperinflation in COPD , 2006, European Respiratory Review.

[9]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[10]  F. Herth,et al.  Endoscopic Lung Volume Reduction , 2009, Respiration.

[11]  R. Zuwallack,et al.  Patient-reported dyspnea in COPD reliability and association with stage of disease. , 2009, Chest.

[12]  H. Magnussen,et al.  Physical activity in patients with COPD , 2008, European Respiratory Journal.

[13]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[14]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[15]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[16]  J. Cooper,et al.  National Emphysema Treatment Trial redux: accentuating the positive. , 2010, The Journal of thoracic and cardiovascular surgery.

[17]  G. McLennan,et al.  A randomized study of endobronchial valves for advanced emphysema. , 2010, The New England journal of medicine.

[18]  N. Hopkinson,et al.  Bronchoscopic lung volume reduction for emphysema: where next? , 2012, European Respiratory Journal.

[19]  M. Noppen,et al.  Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort , 2012, European Respiratory Journal.

[20]  F. Herth,et al.  Segmental Approach to Lung Volume Reduction Therapy for Emphysema Patients , 2014, Respiration.

[21]  F. Herth,et al.  Design of the randomized, controlled sequential staged treatment of emphysema with upper lobe predominance (STEP-UP) study , 2014, BMC Pulmonary Medicine.

[22]  Endoscopic volume reduction in COPD- a critical review. , 2014, Deutsches Arzteblatt international.

[23]  Emphysema: Imaging for Endoscopic Lung Volume Reduction. , 2015, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[24]  R. Huebner,et al.  Lung Volume Reduction in Pulmonary Emphysema from the Radiologist’s Perspective , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[25]  Ipek Oguz,et al.  Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. , 2015, American journal of respiratory and critical care medicine.